Skip to content
10-Q

Quarterly Report

Orchestra BioMed Holdings, Inc. OBIO

0001558370-24-011899

← back to feed
Filed
Aug 12, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 7, 2024 37.82M sh
Cash And Equivalents Q2 2024 · Jun 30, 2024 $23.71M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $30.56M
Current Liabilities Q2 2024 · Jun 30, 2024 $14.5M
Current Liabilities Q2 2024 · Dec 31, 2023 $11.21M
Total Liabilities Q2 2024 · Jun 30, 2024 $28.26M
Total Liabilities Q2 2024 · Dec 31, 2023 $27.17M
Current Assets Q2 2024 · Jun 30, 2024 $66.48M
Current Assets Q2 2024 · Dec 31, 2023 $89.11M
Total Assets Q2 2024 · Jun 30, 2024 $72.38M
Total Assets Q2 2024 · Dec 31, 2023 $95.21M
Shares Diluted Q2 2024 · Jun 30, 2023 34.61M sh
Shares Diluted Q2 2024 · Jun 30, 2023 31.23M sh
Capex Q2 2024 · Jun 30, 2023 $62K
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$24.87M
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.35
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.74
Eps Basic Q2 2024 · Jun 30, 2023 −$0.35
Eps Basic Q2 2024 · Jun 30, 2023 −$0.74
Sga Expense Q2 2024 · Jun 30, 2023 $5.32M
Sga Expense Q2 2024 · Jun 30, 2023 $9.73M
Rd Expense Q2 2024 · Jun 30, 2023 $8.5M
Rd Expense Q2 2024 · Jun 30, 2023 $16.75M
Net Income Q2 2024 · Jun 30, 2023 −$12.05M
Net Income Q2 2024 · Jun 30, 2023 −$22.99M
Net Income Q2 2024 · Mar 31, 2023 −$10.94M
Operating Income Q2 2024 · Jun 30, 2023 −$12.96M
Operating Income Q2 2024 · Jun 30, 2023 −$24.5M
Cost Of Revenue Q2 2024 · Jun 30, 2023 $54K
Cost Of Revenue Q2 2024 · Jun 30, 2023 $98K
Revenue Q2 2024 · Jun 30, 2023 $915K
Revenue Q2 2024 · Jun 30, 2023 $2.08M